 Ideas for or from an evolving healthcare system CMS has a current NCD for biomarker CRC screening, using 74% sensitivity and 90% specificity as a benchmark. This means you pick up about 3/4 of cancers (relative to colonoscopy) and you send about 10 patients per 100 to a false positive based colonoscopy.Here I expand on a prior blog and show the two new CMS options graphically.We can show the statistical space on a probability chart. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. | 
